Thrombolytic Therapy With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke-Reference-Cited by-同舟云学术

Thrombolytic Therapy With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke

Published:2003-06 Issue:6 Volume:34 Page:1437-1442
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Wardlaw J.M.¹,Sandercock P.A.G.¹,Berge E.¹

Affiliation:

1. From the Department of Clinical Neurosciences, Western General Hospital, Edinburgh, UK.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference47 articles.

1. Cavitary Lung Disease

2. Royal College of Physicians of London. National clinical guidelines for stroke. Available at http://www.rcplondon.ac.uk/college/ceeu_stroke _home.htm. 2001. Accessed June 2002.

3. Tissue plasminogen activator for acute ischemic stroke: Is the CAEP Position Statement too negative?

4. Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro analysis of mechanism of pulsed-laser thrombolysis;PLOS ONE;2022-01-27

2. Ethical issues in stroke thrombolysis revisited;Acta Neurologica Scandinavica;2021-11-02

3. Restoration of HDAC1 Enzymatic Activity after Stroke Protects Neurons from Ischemia/Reperfusion Damage and Attenuates Behavioral Deficits in Rats;International Journal of Molecular Sciences;2021-09-30

4. Effect of antiplatelet preparation before endovascular thrombectomy for cerebral infarction on procedural thromboembolisms;Turkish Neurosurgery;2021

5. Liquid biopsy markers for stroke diagnosis;Expert Review of Molecular Diagnostics;2020-07-05